Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine
about
Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimersSelective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertensionAldosterone suppression with dopamine infusion in low-renin hypertensionExercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndromeRenal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Endogenous renal dopamine and control of blood pressure.Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients.Innervation of the adrenal cortex, its physiological relevance, with primary focus on the noradrenergic transmission.Fenoldopam: effect on aldosterone secretion.Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies.Lack of prolactin involvement in corticosteroid secretion.Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study.Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.Nocturnal oscillations of plasma aldosterone in relation to sleep stages.
P2860
Q30248429-AD5774EC-DB63-4604-B975-11F9061605C2Q30436711-016A9EF2-BE81-4429-866E-3906BFD2385DQ30449406-27F22FF8-E144-4C74-9E1C-FC1CD9289749Q33822178-6DD1FEF7-666E-47A9-B6DA-C78D2C1B53F3Q34630458-BFA1B29E-632E-4A51-BC46-19332858FD87Q35357649-AA7E7E20-3CCF-423C-AC47-B5480188536CQ35489697-FAE8E1F6-C91F-4C19-8528-C262904E8F80Q36709425-334820BF-A4AE-4186-A860-DBDC0FCBE3BCQ38751931-E5BCFFAB-85D7-4F20-B9A6-552F172CDD3EQ39665613-13222AF3-9952-4BDC-9E04-525F237F4C68Q41338264-3150C01C-D546-4F52-B6A9-C8C68B4F0639Q41463589-23162A33-4CDC-4EED-BD4D-04C3D3EE4889Q41857537-B8E62742-17EE-4BA6-91D3-2AC2CC405372Q42054203-540084DD-F84A-497B-A8CD-AA1EEF43ECD1Q42523208-05C87A05-41D8-4CD8-8AC1-0B66A91C1016Q46154656-85557B82-74C5-4732-8B69-EB5EAA1832B1Q47148464-78D1D55D-D617-428F-BAAF-6F5506155ADCQ48877133-F3A01390-DC73-47A1-A25E-3EC0FFD40672Q48920259-6018329C-84FE-489B-BE49-2F8F18CFD6FF
P2860
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine
description
1980 nî lūn-bûn
@nan
1980 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@ast
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@en
type
label
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@ast
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@en
prefLabel
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@ast
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@en
P2093
P2860
P356
P1476
Dopaminergic inhibition of met ...... to dopamine and bromocriptine
@en
P2093
P2860
P356
10.1172/JCI109822
P407
P577
1980-07-01T00:00:00Z